Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients
Clinical trial NCT01422876 · COMPLETED
Trial details
- NCT number
- NCT01422876
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2013-09-01
- Enrollment
- 1405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.